Your session is about to expire
← Back to Search
CHAMPS for Psychosis (CHAMPS Trial)
CHAMPS Trial Summary
This trial is testing an app called CHAMPS that gives cannabis users strategies for safer use. The goals of the study are to see if the app is acceptable to users and if it has positive impacts on their health and cannabis consumption habits.
- Psychosis
- Young Adults
- Cannabis Use
CHAMPS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCHAMPS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CHAMPS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have used cannabis at least once in the last 4 weeks.You are able to comply with study procedures.You are willing to adjust your use of cannabis.You cannot participate in the study if you have any of these conditions:You are currently receiving help from a therapist or taking medication to reduce or stop your use of cannabis.You are currently involved in another study that focuses on cannabis.You have been diagnosed with a mental disorder that can cause hallucinations or delusions, such as schizophrenia or bipolar disorder with psychotic features.You have been diagnosed with a mental disorder that can cause hallucinations or severe disturbances in thinking and behavior.You have used cannabis within the past 4 weeks.You are willing to make changes to your cannabis-related habits.
- Group 1: CHAMPS and EIS
- Group 2: EIS alone
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many facilities are managing this clinical trial?
"For this trial, 5 sites are accepting participants: Clinic Notre-Dame des Victoires - Centre de Recherche CERVO in Québec; Nova Scotia Early Psychosis Program in Halifax; Clinique JAP at the Centre hospitalier de l'Université de Montréal and 2 other medical centres."
Does this research project remain open to new participants?
"According to clinicaltrials.gov, this medical study is not actively enrolling patients at the moment; it was first posted on August 23rd 2021 and last updated September 13th 2021. However, there are 554 other trials that currently require participants for their research."
Is the cutoff age for inclusion in this experiment restricted to those below 45 years?
"As detailed in the eligibility requirements, this medical trial is limited to individuals between 18 and 35 years of age. For patients outside of this range, there are 130 research studies dedicated to those below 18 years old and 308 for participants over 65."
What is the objective of this investigation?
"The primary metric of success for this 12-week trial is participant retention. Secondary objectives revolve around efficacy and satisfaction, as measured by changes in the Readiness-to-Change Questionnaire modified for cannabis use, the Short Form Protective Behavioral Strategies-Marijuana questionnaire., and a Client Satisfaction Questionnaire respectively."
What criteria must potential participants fulfill to be considered for this clinical trial?
"This experiment is aiming to recruit 100 young adults with ages ranging from 18-35. To be eligible, participants must ensure that: they are available for the full duration of the study and able to follow through on its procedures; not have used cannabis in the past 4 weeks; open to making changes related to their cannabis consumption; free of any psychiatric disorder such as schizophrenia, schizoaffective disorder, bipolar disorder with psychotic features or others specified under substance-induced psychosis."
Who else is applying?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger